Clinical Trial Update: Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating the effect of liraglutide on epicardial fat in people with type 2 diabetes and overweight/obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University of Miami | Conditions: Type 2 Diabetes, Overweight | Phase 4 | Status: COMPLETED | Results posted: 2018-03-22